Open Arsenal

Tracking Efficacy, Empowering Research

CureLens is an open-source research platform designed to improve transparency and analytical depth in the evaluation of clinical trials. It focuses on systematically comparing intervention outcomes against placebo groups to better understand real-world efficacy. The platform is built around the idea that patterns hidden within trial data, especially in placebo responses, can reveal important insights about treatment effectiveness, study design quality, and potential areas for further scientific investigation.

One of CureLens’ core features is its ability to flag studies where placebo performance reaches or exceeds a defined threshold, prompting deeper review of those interventions. This helps researchers identify cases where outcomes may warrant replication, re-evaluation, or closer methodological inspection. Beyond flagging, the system organizes trial data in a structured way that allows for subgroup comparisons, longitudinal outcome tracking, and cross-study meta-analysis.

CureLens also emphasizes the discovery of broader patterns in health outcomes, including potential signals related to lifestyle, environmental, and behavioral factors that may influence placebo responses. By applying analytical and AI-assisted methods, the platform supports the identification of trends that might otherwise remain hidden within isolated studies. This includes anomaly detection, effect size comparison, and structured evaluation of trial consistency over time.

Overall, CureLens is designed as a tool for researchers, developers, and scientific communities to explore clinical data more critically and transparently. It aims to support reproducible science by combining structured data analysis, visualization, and collaborative contribution into a unified open-source ecosystem.

This specification is released under the GNU Affero General Public License v3.0 or later (AGPL-3.0+) and may be used freely with required attribution under Section 7. A Specification Branding License is available for attribution-free deployments, with fees based on usage, scope, and deployment size.